Delivery Order SPE2DB24D8003-SPE2DB25FJUCE

Award Date 3/28/25
Potential Completion Date 3/31/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4566327375 - Methylphenidate ER 36 MG Tablets in 100 count bottles. The contract has a ceiling value of $1,664.43 and a period of performance through November 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC), SPE2DB24D8001, held by Dakota Drug, Inc. under the DLA Troop Support...
This is a $11,364.25 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the supply of METHYLPHENIDATE ER 54 MG TAB 100S and does not have a set-aside designation. Dakota Drug, Inc. is an experienced prime contractor that has provided a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support the medical supply chain...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 100 bottles of 30mg extended-release methylphenidate tablets to support military medical operations. The contract has a total ceiling value of $1,424.57 and a period of performance through October 16, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,027.24 firm fixed price contract is for the delivery of 4,563,197,924 units of Methylphenidate ER 27 mg tablets in 100 count packages. This contract has an ultimate completion date of December 29, 2023. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $7,937.66 firm fixed-price contract is for the supply of 4,564,042,715 units of the pharmaceutical product Methylphenidate ER 27 mg tablets with an ultimate completion date of March 22, 2024. No set-aside was used for this award. Dakota Drug, Inc. has over two decades of experience as a prime contractor to the federal government,...
The Defense Logistics Agency (DLA) awarded a $5,476.61 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,565,321,317 units of Methylphenidate ER 18 mg tablets. This order falls under Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4,567,223,219 units of Methylphenidate ER 54 mg tablets in 100-count bottles. The contract has a firm fixed price of $3,300.05 and a period of performance through February 11, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., identified as SPE2DB24D8001,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,178.40 firm fixed-price delivery order, identified as SPE2DB24FKYZG, is for the supply of 4,565,632,881 units of Methylphenidate ER 27 mg tablets in 100-count bottles. This order is part of a larger Indefinite Delivery Contract (IDC), SPE2DB24D8001,...
This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJTSW, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,716.06 firm fixed-price delivery order is for the supply of 4567090744 METHYLPHENIDATE ER 27 MG TAB 100S. This contract has an ultimate completion date of January 30, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., identified as SPE2DB24D8001,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,567,720,329 units of Methylphenidate ER 27 mg tablets in 100-count bottles. The $6,259.23 contract has a performance period ending on March 28, 2025. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the agency's ECAT Generation V Program, which allows the company to...
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJUCE
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,403.08, is for the delivery of 4567733259 METHYLPHENIDATE ER 36 MG TAB 100S. The contract is a firm-fixed-price type, with a period of performance through March 31, 2025. This contract does not have a set-aside designation. Dakota Drug, Inc. is the prime contractor and sole awardee. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which enables the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations.

Generated 6/27/25, 12:07 PM